HomeAMBUJACEM › Filing
🔔 Get instant alerts when AMBUJACEM files quarterly results on BSE Start free trial →

Statement of deviation(s) or variation(s) under Reg. 32

Filed: 28 Jul 2026, 14:38 IST Exchange: NSE Category: Regulatory Compliance — Statement of Deviation
Statement of deviation under Reg. 32 for preferential issue funds: No deviation or variation in use of proceeds for quarter ended June 30, 2026. Total funds raised Rs 15000.046 Cr fully utilized as per original allocation. Audit Committee reviewed and approved. No comments from auditors or committee.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 AMBUJACEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add AMBUJACEM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Ambuja Cements Limited

Important. The summary above is generated automatically from Ambuja Cements Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.